Individualized parotidectomy to reduce the incidence of postoperative facial paralysis for primary benign parotid neoplasms

Objective: The aim of this study was to evaluate the role of individualized parotidectomy to reduce the incidence of postoperative facial paralysis for primary benign parotid tumors. Methods: A total of 154 consecutive patients who underwent individualized parotidectomy for benign parotid gland neop...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yu Zhou, Xianjie Duan, Chengyun Si, Chuanjun Chen, Hui Peng, Zhihong Zhang
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2022
Materias:	Parotid gland Benign neoplasm Parotidectomy Facial nerve Facial paralysis Risk factors Internal medicine RC31-1245 Surgery RD1-811
Acceso en línea:	https://doaj.org/article/eddf5ab9bd9043e4932a8e570b576544
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:eddf5ab9bd9043e4932a8e570b576544
record_format	dspace
spelling	oai:doaj.org-article:eddf5ab9bd9043e4932a8e570b5765442021-11-04T04:44:15ZIndividualized parotidectomy to reduce the incidence of postoperative facial paralysis for primary benign parotid neoplasms2667-147610.1016/j.adoms.2021.100187https://doaj.org/article/eddf5ab9bd9043e4932a8e570b5765442022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S266714762100176Xhttps://doaj.org/toc/2667-1476Objective: The aim of this study was to evaluate the role of individualized parotidectomy to reduce the incidence of postoperative facial paralysis for primary benign parotid tumors. Methods: A total of 154 consecutive patients who underwent individualized parotidectomy for benign parotid gland neoplasms were retrospectively reviewed. We analyzed the incidence and the significant risk factors associated with postoperative facial paralysis after individualized parotidectomy. Results: Postoperative transient FP was observed in 25 patients (16.2%). None of the patients developed a recurrence or permanent facial paralysis. Grade II facial nerve function was predominant (92.0%) and no patient had grade VI. Among the 25 patients, the facial nerve function of 93.6% of patients recovered in 3 months, and function had recovered in 100% of patients in 6 months. Tumor location, tumor size and surgery extent were the significant and independent risk factors associated with postoperative facial paralysis after individualized parotidectomy. Conclusion: Individualized parotidectomy can effectively reduce the incidence of postoperative facial paralysis and shorten the recovery time of facial nerve injury for primary benign parotid neoplasms.Yu ZhouXianjie DuanChengyun SiChuanjun ChenHui PengZhihong ZhangElsevierarticleParotid glandBenign neoplasmParotidectomyFacial nerveFacial paralysisRisk factorsInternal medicineRC31-1245SurgeryRD1-811ENAdvances in Oral and Maxillofacial Surgery, Vol 5, Iss , Pp 100187- (2022)
institution	DOAJ
collection	DOAJ
language	EN
topic	Parotid gland Benign neoplasm Parotidectomy Facial nerve Facial paralysis Risk factors Internal medicine RC31-1245 Surgery RD1-811
spellingShingle	Parotid gland Benign neoplasm Parotidectomy Facial nerve Facial paralysis Risk factors Internal medicine RC31-1245 Surgery RD1-811 Yu Zhou Xianjie Duan Chengyun Si Chuanjun Chen Hui Peng Zhihong Zhang Individualized parotidectomy to reduce the incidence of postoperative facial paralysis for primary benign parotid neoplasms
description	Objective: The aim of this study was to evaluate the role of individualized parotidectomy to reduce the incidence of postoperative facial paralysis for primary benign parotid tumors. Methods: A total of 154 consecutive patients who underwent individualized parotidectomy for benign parotid gland neoplasms were retrospectively reviewed. We analyzed the incidence and the significant risk factors associated with postoperative facial paralysis after individualized parotidectomy. Results: Postoperative transient FP was observed in 25 patients (16.2%). None of the patients developed a recurrence or permanent facial paralysis. Grade II facial nerve function was predominant (92.0%) and no patient had grade VI. Among the 25 patients, the facial nerve function of 93.6% of patients recovered in 3 months, and function had recovered in 100% of patients in 6 months. Tumor location, tumor size and surgery extent were the significant and independent risk factors associated with postoperative facial paralysis after individualized parotidectomy. Conclusion: Individualized parotidectomy can effectively reduce the incidence of postoperative facial paralysis and shorten the recovery time of facial nerve injury for primary benign parotid neoplasms.
format	article
author	Yu Zhou Xianjie Duan Chengyun Si Chuanjun Chen Hui Peng Zhihong Zhang
author_facet	Yu Zhou Xianjie Duan Chengyun Si Chuanjun Chen Hui Peng Zhihong Zhang
author_sort	Yu Zhou
title	Individualized parotidectomy to reduce the incidence of postoperative facial paralysis for primary benign parotid neoplasms
title_short	Individualized parotidectomy to reduce the incidence of postoperative facial paralysis for primary benign parotid neoplasms
title_full	Individualized parotidectomy to reduce the incidence of postoperative facial paralysis for primary benign parotid neoplasms
title_fullStr	Individualized parotidectomy to reduce the incidence of postoperative facial paralysis for primary benign parotid neoplasms
title_full_unstemmed	Individualized parotidectomy to reduce the incidence of postoperative facial paralysis for primary benign parotid neoplasms
title_sort	individualized parotidectomy to reduce the incidence of postoperative facial paralysis for primary benign parotid neoplasms
publisher	Elsevier
publishDate	2022
url	https://doaj.org/article/eddf5ab9bd9043e4932a8e570b576544
work_keys_str_mv	AT yuzhou individualizedparotidectomytoreducetheincidenceofpostoperativefacialparalysisforprimarybenignparotidneoplasms AT xianjieduan individualizedparotidectomytoreducetheincidenceofpostoperativefacialparalysisforprimarybenignparotidneoplasms AT chengyunsi individualizedparotidectomytoreducetheincidenceofpostoperativefacialparalysisforprimarybenignparotidneoplasms AT chuanjunchen individualizedparotidectomytoreducetheincidenceofpostoperativefacialparalysisforprimarybenignparotidneoplasms AT huipeng individualizedparotidectomytoreducetheincidenceofpostoperativefacialparalysisforprimarybenignparotidneoplasms AT zhihongzhang individualizedparotidectomytoreducetheincidenceofpostoperativefacialparalysisforprimarybenignparotidneoplasms
_version_	1718445246248910848

Individualized parotidectomy to reduce the incidence of postoperative facial paralysis for primary benign parotid neoplasms

Ejemplares similares